XORTX Therapeutics Inc. filed a Form 6-K on April 8, 2024, indicating that they comply with SEC reporting requirements. The filing does not include specific quantitative data but confirms the filing's formalities.
AI Assistant
XORTX THERAPEUTICS INC
2024
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.